The path to safe, equitable and sustainable dialysis provision for people with chronic kidney disease

Yot Teerawattananon^{1

2}, Kinanti Khansa Chavarina³, Jeerath Phannajit^{4

5

6}, Jiratorn Sutawong¹, Natcha Yongphiphatwong⁷, Natasha Chawla¹, Siobhan Botwright^{1

8}, Tanainan Chuanchaiyakul¹, Thunyarat Anothaisintawee⁹, Fatiu Arogundade¹⁰, Gloria Ashuntantang¹¹, Jadej Thammatacharee¹², Laura Sola¹³, Piyathida Chuengsaman¹⁴, Somsak Chunharas¹⁵, Suwit Wibulpolprasert^{16

17}, Sydney C W Tang¹⁸, Talerngsak Kanjanabuch^{4

19}, Valerie Luyckx^{20

21

22}, Vuddhidej Ophascharoensuk²³, Wanrudee Isaranuwatchai^{1

24}, Vivekanand Jha^{25

26

27}, Kearkiat Praditpornsilpa⁴, Kriang Tungsanga^{4

28}; Nature Medicine Commission on Dialysis Policy in Low- and Middle-Income Countries

Collaborators, Affiliations

Collaborators

Nature Medicine Commission on Dialysis Policy in Low- and Middle-Income Countries:
Chulathip Boonma, Saudamini Vishwanath Dabak, Chutidej Tabongkaraksa, Kraiwiporn Kiattisunthorn, Nipa Aiyasanon, Netnapha Sitthitham, Supakit Sirilak, Thanapol Dokkaew, Warangkana Pichaiwong, Suwannee Sriprach, Denla Pandejpong, Dimple Haresh Butani, Henny Aryani, Jutamas Piyawong, Kamol Khositrangsikun, Kridsada Chareonrungruengchai, Naline Gandhi, Natanong Thamcharoen, Nutthawongse Kiatkrissada, Pitsinee Supapol, Rujira Ngam-Prukwanit, Sajja Tatiyanupanwong, Siriyakorn Khamkom, Suchada Boonkaew, Supichcha Thitjuea, Wirun Limsawart

Affiliations

¹ Health Intervention and Technology Assessment Program Foundation, Nonthaburi, Thailand.
² Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore.
³ Health Intervention and Technology Assessment Program Foundation, Nonthaburi, Thailand. kinanti.c@hitap.net.
⁴ Division of Nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
⁵ Division of Clinical Epidemiology, Department of Medicine, King Chulalongkorn Memorial Hospital, Thai Red Cross, Bangkok, Thailand.
⁶ Center of Excellence for Metabolic Bone Disease in Chronic Kidney Disease Patients, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
⁷ Thailand Development Research Institute, Bangkok, Thailand.
⁸ University of Strathclyde, Glasgow, UK.
⁹ Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
¹⁰ Obafemi Awolowo University, Ile-Ife, Nigeria.
¹¹ University of Yaounde I, Yaoundé, Cameroon.
¹² National Health Security Office, Bangkok, Thailand.
¹³ Dialysis Center CASMU-IAMPP, Montevideo, Uruguay.
¹⁴ Continuous Ambulatory Peritoneal Dialysis Service and Training Center, Banphaeo Hospital, Bangkok, Thailand.
¹⁵ Thailand National Health Foundation, Bangkok, Thailand.
¹⁶ International Health Policy Program, Nonthaburi, Thailand.
¹⁷ Office of the Permanent Secretary, Ministry of Public Health, Nonthaburi, Thailand.
¹⁸ Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Hong Kong, China.
¹⁹ Center of Excellence in Kidney and Metabolic Disorders, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
²⁰ The Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
²¹ University of Cape Town, Cape Town, South Africa.
²² University Children's Hospital, University of Zurich, Zurich, Switzerland.
²³ Faculty of Medicine, Chiangmai University, Chiangmai, Thailand.
²⁴ Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
²⁵ The George Institute for Global Health, University of New South Wales, New Delhi, India.
²⁶ School of Public Health, Imperial College, London, UK.
²⁷ Prasanna School of Public Health, Manipal Academy of Higher Education, Manipal, India.
²⁸ Bhumirajanakarindra Kidney Institute Hospital, Bangkok, Thailand.

PMID: 41566044
DOI: 10.1038/s41591-025-04144-1

The path to safe, equitable and sustainable dialysis provision for people with chronic kidney disease

Yot Teerawattananon et al. Nat Med. 2026 Jan.

. 2026 Jan;32(1):44-46.

doi: 10.1038/s41591-025-04144-1.

Authors

Collaborators

Nature Medicine Commission on Dialysis Policy in Low- and Middle-Income Countries:
Chulathip Boonma, Saudamini Vishwanath Dabak, Chutidej Tabongkaraksa, Kraiwiporn Kiattisunthorn, Nipa Aiyasanon, Netnapha Sitthitham, Supakit Sirilak, Thanapol Dokkaew, Warangkana Pichaiwong, Suwannee Sriprach, Denla Pandejpong, Dimple Haresh Butani, Henny Aryani, Jutamas Piyawong, Kamol Khositrangsikun, Kridsada Chareonrungruengchai, Naline Gandhi, Natanong Thamcharoen, Nutthawongse Kiatkrissada, Pitsinee Supapol, Rujira Ngam-Prukwanit, Sajja Tatiyanupanwong, Siriyakorn Khamkom, Suchada Boonkaew, Supichcha Thitjuea, Wirun Limsawart

Affiliations

¹ Health Intervention and Technology Assessment Program Foundation, Nonthaburi, Thailand.
² Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore.
³ Health Intervention and Technology Assessment Program Foundation, Nonthaburi, Thailand. kinanti.c@hitap.net.
⁴ Division of Nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
⁵ Division of Clinical Epidemiology, Department of Medicine, King Chulalongkorn Memorial Hospital, Thai Red Cross, Bangkok, Thailand.
⁶ Center of Excellence for Metabolic Bone Disease in Chronic Kidney Disease Patients, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
⁷ Thailand Development Research Institute, Bangkok, Thailand.
⁸ University of Strathclyde, Glasgow, UK.
⁹ Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
¹⁰ Obafemi Awolowo University, Ile-Ife, Nigeria.
¹¹ University of Yaounde I, Yaoundé, Cameroon.
¹² National Health Security Office, Bangkok, Thailand.
¹³ Dialysis Center CASMU-IAMPP, Montevideo, Uruguay.
¹⁴ Continuous Ambulatory Peritoneal Dialysis Service and Training Center, Banphaeo Hospital, Bangkok, Thailand.
¹⁵ Thailand National Health Foundation, Bangkok, Thailand.
¹⁶ International Health Policy Program, Nonthaburi, Thailand.
¹⁷ Office of the Permanent Secretary, Ministry of Public Health, Nonthaburi, Thailand.
¹⁸ Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Hong Kong, China.
¹⁹ Center of Excellence in Kidney and Metabolic Disorders, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
²⁰ The Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
²¹ University of Cape Town, Cape Town, South Africa.
²² University Children's Hospital, University of Zurich, Zurich, Switzerland.
²³ Faculty of Medicine, Chiangmai University, Chiangmai, Thailand.
²⁴ Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
²⁵ The George Institute for Global Health, University of New South Wales, New Delhi, India.
²⁶ School of Public Health, Imperial College, London, UK.
²⁷ Prasanna School of Public Health, Manipal Academy of Higher Education, Manipal, India.
²⁸ Bhumirajanakarindra Kidney Institute Hospital, Bangkok, Thailand.

PMID: 41566044
DOI: 10.1038/s41591-025-04144-1

No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: V.J. has received consulting fees or honoraria from Bayer, Astra Zeneca, Boehringer Ingelheim, Vera, Visterra, Otsuka, Novartis, Chinook, Biocryst and Alpine under a policy by which all payments go to the George Institute for Global Health. T.K. has received consultancy fees from Visterra, Otsuka and AstraZeneca as a country investigator and has also received speaking honoraria from AstraZeneca, Alexion, Fresenius Medical Care and Baxter Healthcare. S.C.W.T. has received consulting fees or honoraria from Astra Zeneca, Bayer, Boehringer Ingelheim, Everest Medicines, Novartis and Vantive. The other authors declare no competing interests.

References

LinkOut - more resources

Full Text Sources
- Nature Publishing Group

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

The path to safe, equitable and sustainable dialysis provision for people with chronic kidney disease

Collaborators

Affiliations

The path to safe, equitable and sustainable dialysis provision for people with chronic kidney disease

Authors

Collaborators

Affiliations

Conflict of interest statement

References

Further reading

LinkOut - more resources

Full Text Sources